We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$457B
$64M 1.21%
1,108,713
+1,055,835
+1,997% +$58.6M
MCHP icon
27
Microchip Technology
MCHP
$42.8B
$61.8M 1.17%
2,618,096
+25,618
+1% +$612K
TSCO icon
28
Tractor Supply
TSCO
$16B
$61.2M 1.15%
4,976,125
-28,240
-0.6% -$353K
IT icon
29
Gartner
IT
$9.43B
$59.3M 1.12%
807,340
-44,471
-5% -$3.23M
ITC
30
DELISTED
ITC HOLDINGS CORP
ITC
$59.2M 1.12%
1,662,373
+8,085
+0.5% +$294K
PII icon
31
Polaris
PII
$4.17B
$58.4M 1.1%
389,581
+109,743
+39% +$15.9M
EPD icon
32
Enterprise Products Partners
EPD
$84B
$57.9M 1.09%
1,436,380
+4,000
+0.3% +$157K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$57.2M 1.08%
964,279
-484,658
-33% -$31.8M
TSLA icon
34
Tesla
TSLA
$1.22T
$55.1M 1.04%
3,405,540
+747,450
+28% +$12.3M
AAPL icon
35
Apple
AAPL
$4.89T
$54.1M 1.02%
2,149,784
+1,002,876
+87% +$24.6M
UPS icon
36
United Parcel Service
UPS
$97.5B
$54.1M 1.02%
550,044
+5,238
+1% +$520K
AMZN icon
37
Amazon
AMZN
$2.49T
$54M 1.02%
3,348,680
+1,180
+0% +$19.6K
ELV icon
38
Elevance Health
ELV
$82.1B
$52.3M 0.99%
437,499
+47,288
+12% +$5.42M
GILD icon
39
Gilead Sciences
GILD
$162B
$50.6M 0.95%
475,368
-186,727
-28% -$18.3M
GOOG icon
40
Alphabet (Google) Class C
GOOG
$3.9T
$50.5M 0.95%
1,735,391
-30,664
-2% -$887K
MIDD icon
41
Middleby
MIDD
$6.04B
$50.1M 0.95%
569,000
-41,810
-7% -$3.46M
CPAY icon
42
Corpay
CPAY
$24.3B
$49.9M 0.94%
351,349
-98,857
-22% -$13.6M
HD icon
43
Home Depot
HD
$330B
$49.6M 0.94%
540,769
+4,085
+0.8% +$350K
SLXP
44
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$49.5M 0.93%
317,054
+46,314
+17% +$6.71M
ACHC icon
45
Acadia Healthcare
ACHC
$3.19B
$47.9M 0.9%
987,580
-66,819
-6% -$3.27M
KSU
46
DELISTED
Kansas City Southern
KSU
$47.2M 0.89%
389,384
-3,107
-0.8% -$354K
SRCL
47
DELISTED
Stericycle Inc
SRCL
$46.9M 0.88%
402,489
-71,256
-15% -$8.42M
APAM icon
48
Artisan Partners
APAM
$2.8B
$44.9M 0.85%
861,940
+32,200
+4% +$1.74M
DOV icon
49
Dover
DOV
$27.2B
$44.8M 0.84%
690,341
+6,554
+1% +$461K
BX icon
50
Blackstone
BX
$103B
$43.8M 0.82%
1,416,698
+259,814
+22% +$8.45M

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.